Literature DB >> 9529396

Immunosuppressive drugs after lung transplantation.

N Briffa, R E Morris.   

Abstract

Mesh:

Substances:

Year:  1998        PMID: 9529396      PMCID: PMC1112721     

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  13 in total

Review 1.  Molecular mechanisms of action of new xenobiotic immunosuppressive drugs: tacrolimus (FK506), sirolimus (rapamycin), mycophenolate mofetil and leflunomide.

Authors:  T R Brazelton; R E Morris
Journal:  Curr Opin Immunol       Date:  1996-10       Impact factor: 7.486

2.  The Registry of the International Society for Heart and Lung Transplantation: thirteenth official report--1996.

Authors:  J D Hosenpud; R J Novick; L E Bennett; B M Keck; B Fiol; O P Daily
Journal:  J Heart Lung Transplant       Date:  1996-07       Impact factor: 10.247

3.  The International Society for Heart and Lung Transplantation 16th annual meeting and scientific sessions. New York, New York, March 15-18, 1996. Abstracts.

Authors: 
Journal:  J Heart Lung Transplant       Date:  1996-01       Impact factor: 10.247

4.  The International Society for Heart and Lung Transplantation 17th annual meeting and scientific sessions. London, England, April 2-5, 1997. Abstracts.

Authors: 
Journal:  J Heart Lung Transplant       Date:  1997-01       Impact factor: 10.247

Review 5.  Sirolimus: a new agent for clinical renal transplantation.

Authors:  B D Kahan
Journal:  Transplant Proc       Date:  1997 Feb-Mar       Impact factor: 1.066

6.  Methotrexate can halt the progression of bronchiolitis obliterans syndrome in lung transplant recipients.

Authors:  M Dusmet; J Maurer; T Winton; S Kesten
Journal:  J Heart Lung Transplant       Date:  1996-09       Impact factor: 10.247

7.  Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups.

Authors:  P Halloran; T Mathew; S Tomlanovich; C Groth; L Hooftman; C Barker
Journal:  Transplantation       Date:  1997-01-15       Impact factor: 4.939

8.  Clinical trial of tacrolimus versus cyclosporine in lung transplantation.

Authors:  R J Keenan; H Konishi; A Kawai; I L Paradis; D R Nunley; A T Iacono; R L Hardesty; R J Weyant; B P Griffith
Journal:  Ann Thorac Surg       Date:  1995-09       Impact factor: 4.330

9.  The relative effects of FK506 and cyclosporine on short- and long-term kidney graft survival.

Authors:  D W Gjertson; J M Cecka; P I Terasaki
Journal:  Transplantation       Date:  1995-12-27       Impact factor: 4.939

10.  Aerosolized cyclosporine in lung recipients with refractory chronic rejection.

Authors:  A T Iacono; R J Keenan; S R Duncan; G C Smaldone; J H Dauber; I L Paradis; N P Ohori; W F Grgurich; G J Burckart; A Zeevi; E Delgado; T G O'Riordan; M M Zendarsky; S A Yousem; B P Griffith
Journal:  Am J Respir Crit Care Med       Date:  1996-04       Impact factor: 21.405

View more
  2 in total

Review 1.  Exploiting novel molecular targets in gastrointestinal cancers.

Authors:  Wen W Ma; Manuel Hidalgo
Journal:  World J Gastroenterol       Date:  2007-11-28       Impact factor: 5.742

2.  Effects of immune suppression for transplantation on inflammatory colorectal cancer progression.

Authors:  Imerio Angriman; Lucrezia Furian; Melania Scarpa; Matteo Fassan; Susan Morgan; Andrea Porzionato; Andromachi Kotsafti; Luca Saadeh; Cristina Silvestre; Raffaele De Caro; Amedeo Carraro; Umberto Tedeschi; Romeo Bardini; Paolo Rigotti; Massimo Rugge; Carlo Castoro; Ignazio Castagliuolo; Marco Scarpa
Journal:  Oncogenesis       Date:  2018-06-19       Impact factor: 7.485

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.